RadiaDyn: RadiaDyne Snags Clearance for Two Additional FDA Indications for the OARtrac System
RadiaDyne announces it received notice of additional FDA clearance for two new Indications of Use for their upcoming OARtrac radiation dose monitoring platform.
Read full article »
RadiaDyn designs and develops dosage monitoring devices to improve cancer treatment outcomes.
Read more